Family Medicine Doctors in Hillsboro, TX Accepting Medicare
7 Family Medicine doctors found. Showing 1 - 7
 Dr. Jeremiah Brent Seely, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1323 E. Franklin St., Suite 105, Hillsboro, TX 76645 Phone: 254-582-7481 Fax: 254-580-1584 |
Dr. Wesley C Marshall, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1323 E Franklin St, Suite 105, Hillsboro, TX 76645 Phone: 254-582-7481 Fax: 254-580-1584 |
Jason R Bauerschlag, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1323 E Franklin St, Suite 105, Hillsboro, TX 76645 Phone: 254-582-7481 Fax: 254-580-1584 |
 Britney Lee Burnett, FNP Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1200 Corsicana Hwy, Hillsboro, Tx 76645, Hillsboro, TX 76645 Phone: 254-651-1769 |
Dr. Steve Nelson Martin Jr., MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 101 Circle Dr, Hillsboro, TX 76645 Phone: 254-580-8911 |
James M Earhart, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1323 E Franklin St, Suite 105, Hillsboro, TX 76645 Phone: 254-582-7481 Fax: 254-580-1584 |
Christopher W Teague, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1323 E. Franklin St., Suite 105, Hillsboro, TX 76645 Phone: 254-582-7481 Fax: 254-580-1584 |
News Archive
High calcium intake raises all cause, CVD mortality risk for women
Latest research examining the potential hazards of a high calcium intake finds an increased mortality risk among women with a high intake through diet and supplements.
Clinical Genomics introduces new blood-based test for CRC recurrence monitoring
Clinical Genomics, a private company developing evidence-based diagnostic tools for colorectal cancer, today announced the launch of Colvera, a blood-based test for colorectal cancer (CRC) recurrence monitoring. Colvera is the result of a decade of research, development and clinical validation in more than 4,000 patients.
FDA Advisory Committee recommends approval of dabigatran etexilate for stroke prevention in AFib patients
The U.S. Food and Drug Administration (FDA) Cardiovascular and Renal Drugs Advisory Committee today voted 9 to 0 in favor of approving dabigatran etexilate for stroke prevention in patients with atrial fibrillation (AFib). An estimated 2.3 million Americans have AFib and the prevalence is expected to increase 2.5 fold to 5.6 million by 2050, reflecting the growing population of elderly individuals.
Delayed introduction of complementary baby foods may influence weight: Study
Benjamin Franklin's advice that "an ounce of prevention is worth a pound of cure" can easily be applied to today's most pressing health issue: obesity. Because taking off extra weight is an almost insurmountable challenge, preventing the progression of weight gain throughout life, especially childhood, is crucial to realizing optimal long-term health.
› Verified 4 days ago
Family Medicine
Surgery
Internal Medicine
Physical Medicine & Rehabilitation
Pediatrics